Advances in Experimental Medicine and Biology 1005 Bairong Shen Editor Translational Informatics in Smart Healthcare Advances in Experimental Medicine and Biology Volume 1005 EditorialBoard IRUNR.COHEN,TheWeizmannInstituteofScience,Rehovot,Israel ABEL LAJTHA, N.S., Kline Institute for Psychiatric Research, Orangeburg, NY,USA JOHND.LAMBRIS,UniversityofPennsylvania,Philadelphia,PA,USA RODOLFOPAOLETTI,UniversityofMilan,Milan,Italy Moreinformationaboutthisseriesathttp://www.springer.com/series/5584 Bairong Shen Editor Translational Informatics in Smart Healthcare Editor BairongShen CenterforSystemsBiology SoochowUniversity Suzhou,Jiangsu,China ISSN0065-2598 ISSN2214-8019 (electronic) AdvancesinExperimentalMedicineandBiology ISBN978-981-10-5716-8 ISBN978-981-10-5717-5 (eBook) DOI10.1007/978-981-10-5717-5 LibraryofCongressControlNumber:2017951623 ©SpringerNatureSingaporePteLtd.2017 Thisworkissubjecttocopyright.AllrightsarereservedbythePublisher,whetherthewholeorpartof the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilarmethodologynowknownorhereafterdeveloped. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publicationdoesnotimply,evenintheabsenceofaspecificstatement,thatsuchnamesareexempt fromtherelevantprotectivelawsandregulationsandthereforefreeforgeneraluse. Thepublisher,theauthorsandtheeditorsaresafetoassumethattheadviceandinformationinthis book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained hereinor for anyerrors oromissionsthat may havebeenmade. Thepublisher remainsneutralwith regardtojurisdictionalclaimsinpublishedmapsandinstitutionalaffiliations. Printedonacid-freepaper ThisSpringerimprintispublishedbySpringerNature TheregisteredcompanyisSpringerNatureSingaporePteLtd. The registered company address is: 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore Contents 1 InformaticsforPrecisionMedicineandHealthcare. . . . . . . . . . . . . 1 JiajiaChen,YuxinLin,andBairongShen 2 GeneticTest,RiskPrediction,andCounseling. . . . . . . . . . . . . . . . . 21 MaggieHaitianWangandHaoyiWeng 3 NewbornScreeningintheEraofPrecisionMedicine. . . . . . . . . . . . 47 LanYang,JiajiaChen,andBairongShen 4 TraceElementsandHealthcare:ABioinformaticsPerspective. . . . 63 YanZhang 5 TongueImageAnalysisandItsMobileAppDevelopment forHealthDiagnosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99 RatchadapornKanawong,TayoObafemi-Ajayi,DahaiLiu, MengZhang,DongXu,andYeDuan 6 PhysicalExercisePrescriptioninMetabolicChronicDisease. . . . . . 123 LauraStefaniandGiorgioGalanti 7 InformaticsforNutritionalGeneticsandGenomics. . . . . . . . . . . . . 143 YuanGaoandJiajiaChen 8 InteractionsBetweenGenetics,Lifestyle,andEnvironmental FactorsforHealthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167 YuxinLin,JiajiaChen,andBairongShen 9 CohortResearchin“Omics”andPreventiveMedicine. . . . . . . . . . 193 YiShen,ShengZhang,JieZhou,andJiajiaChen v Chapter 1 Informatics for Precision Medicine and Healthcare JiajiaChen,YuxinLin,andBairongShen Abstract Thepastdecadehaswitnessedgreatadvancesinbiomedicalinformatics. Biomedicalinformaticsisanemergingfieldofhealthcarethataimstotranslatethe laboratory observation into clinical practice. Smart healthcare has also developed rapidly with ubiquitous sensor and communication technologies. It is able to capture the online patient-centric phenotypic variables, thus providing a rich information basefor translational biomedicalinformatics.Biomedicalinformatics andsmarthealthcare representtwointerrelateddisciplines.Ononehand,biomed- ical informatics translates the bench discoveries into bedside, and, on the other hand,itisreciprocallyinformedbyclinicaldatageneratedfromsmarthealthcare. In this chapter, we will introduce the major strategies and challenges in the application of biomedical informatics technology in precision medicine and healthcare.Wehighlighthowtheinformaticstechnologywillpromotetheprecision medicineandthereforepromisetheimprovementofhealthcare. Keywords Healthcare•Informatics•Precisionmedicine•Sensor J.Chen SchoolofChemistry,BiologyandMaterialsEngineering,SuzhouUniversityofScienceand Technology,No.1Keruiroad,Suzhou,Jiangsu215011,China Y.Lin CenterforSystemsBiology,SoochowUniversity,No.1ShiziStreet,Suzhou,Jiangsu215006, China B.Shen(*) CenterforSystemsBiology,SoochowUniversity,No.1ShiziStreet,Suzhou,Jiangsu215006, China SuzhouInstituteofBiomedicalEngineeringandTechnology,ChineseAcademyofSciences, Suzhou,Jiangsu215163,China MedicalCollegeofGuizhouUniversity,Guiyang550025,China e-mail:[email protected] ©SpringerNatureSingaporePteLtd.2017 1 B.Shen(ed.),TranslationalInformaticsinSmartHealthcare,Advancesin ExperimentalMedicineandBiology1005,DOI10.1007/978-981-10-5717-5_1 2 J.Chenetal. 1.1 Introduction In the 2015 State of the Union address, US President Barack Obama launched Precision Medicine Initiative (PMI) with a national investment of $215 million [1]. PMI will pioneer biomedical research that takes into account the individual variability ingenes, environment, andlifestyle [2], thereby leading to the patient- centered healthcare. Precision medicine falls within the scope of P4 medicine, which is preventive, predictive, personalized, and participatory [3]. It will change thehealthcarefromitscurrentreactivemodetoamoreproactiveandrationalone. In P4 medicine, clinicians focus on prevention rather than disease management. Theycandetermineaprioritheriskandtherapeuticresponsesofeachpatientbased on unique genetic makeup and customize medical treatment. P4 medicine also enables individuals to become active and responsible participants in their own health[4]. P4medicineishighlydependentontheavailabilityoftrustablebiomedicaldata and the ability to manage the heterogeneous datasets with high levels of dimen- sionality.Translationalbiomedicalinformatics(TBI)isarapidlyemergingfieldof health informatics to advance P4 medicine. High-throughput technologies represented by next-generation sequencing have generated myriad of biomedical information at different levels, from the molecules to tissues, individuals, and all the way to population [5]. The fields of molecular, imaging, clinical, and public health informatics are converging into the emerging field of TBI [6]. TBI mainly exploitstheheterogeneousdatawealthfromthebenchtoformulateknowledgefor bedsideapplication[7]. TheprospectofapplyingP4medicinehasbeenboostedstillfurtherbytherecent developmentofsmarthealthcaretechnologies[8].Smarthealthcareisarecentterm for healthcare practice. It typically refers to the use of smart devices with the capability to generate and disseminate health information to deliver healthcare services. Smart devices are a set of advanced electronics, sensors, and ubiquitous computing devices connected via different network protocols that can operate interactivelyandautonomously[9]. In addition to smart healthcare, there are several competing terms including eHealth,mHealth,telemedicine,andconnectedhealth,eachofwhichhastheirown definitions.TheWHO’sdefinitionofeHealthisthe“cost-effectiveandsecureuse of information and communications technologies in support of health and health related fields.” [10] This is a broad definition including several subfields such as telemedicine,mHealth,andconnectedhealth.Telemedicineemploysmoderncom- munication technologies to transfer medical information among treatment sites improving healthcare [11]. mHealth is the successor to telemedicine, which describes the delivery of healthcare services via mobile devices [12, 13] such as cellphonesandlaptops.Connectedhealthalsooriginatesfromtelemedicine,which is a healthcare delivery model that uses advanced technologies to provide healthcare remotely [14, 15]. Although smart healthcare partially overlap in 1 InformaticsforPrecisionMedicineandHealthcare 3 definitionwithmhealth,itisdistinguishedfrommhealthbyawiderrangeofsensors andconsumerelectronicgoodsandmoreubiquitouscomputingproperties. Technologicaladvancesinsensingandcommunicationaretwoenablersforthe deliveryofsmarthealthcareservices.Sensingtechnologyenablesasmartphysical environment inwhich nontraditional data on individual activities and lifestyle are recordedbysmartsensors[16].Networkingandcommunicationincreasethereach and mobility of healthcare providers and also enable users to access pertinent services anywhere and anytime. Therefore, smart healthcare represents a frame- workintegratinginnovativenetworkingandcommunicationtechnologies,medical sensor, and ubiquitous computing devices for improved healthcare delivery and services. The penetration of smart device has been substantial within the medical communityandcontinuestogrow.Asaresult,smarthealthcareistransformingthe deliveryofhealthcareinvirtuallyallareasofmedicine. Information is the bedrock upon which translational biomedical informatics drivestranslation.Theincreasingamountandvarietyofdatafromsmarthealthcare ononehandhaswidentheTBI’sarsenaltoacquirerelevantdataand,ontheother hand,inevitablyaddedtodatacomplexity[17].Inthispaperwedescribehowthe partnershipbetweenTBIandsmarthealthcareisexpectedtocatalyzeaneweraof P4 medicine. We also discuss the fundament issues and challenges inthe integra- tionoftwodomainsforimprovedhealthcaredelivery. 1.2 Search Strategy Forthisliteraturereview,wesearchedMEDLINEcitationsandWebofSciencefor all papers that discuss the use of smart health technologies by healthcare pro- fessionals or patients. We performed a complex query which included various search terms appearing in the title or abstract. The search terms used for eligible articles were “smart, sensors, healthcare, informatics, vital signs, P4 medicine, translational,internet.”Thesearchwasrestrictedtojournalpapersthatwerewritten inEnglishandpublisheduntilSeptember20,2015.Tobefullyinclusive,wealso searchedreferencelistsintheretrievedpapers.Titlesandabstractswerereviewed byahumanforeligibility.Paperswereexcludediftheywerenotdirectlyrelatedto smarthealthcare.Full-textpaperswereretrievedfollowedbyafull-textreview. 1.3 TBI and Smart Healthcare Technologicalinnovationsinhigh-throughputexperimentaltechniques,e.g.,next- generation sequencing and molecular imaging have produced unprecedented vol- ume of biomedical data. This data wealth is making the research community, includingbiomedicalscientistsandclinicianswellinformedonthegenetic,geno- mic, clinical, and environmental background of the patient. However, such high- 4 J.Chenetal. dimensional data spans multiple disciplines and are often difficult to apply in practice. Translational biomedical informatics is an emerging field of healthcare that supports the transfer of biological observations from bench into rational care at thebedside.Translationalbiomedicalinformaticsencompassesfoursubdisciplines: bioinformatics, imaging informatics, clinical informatics, and public health infor- matics [18]. Each subdiscipline aims at a unique research domain and therefore features domain-specific informatics tools and output formats. Table 1.1 summa- rizesthespectrumofTBIdisciplines.ThefoursubdisciplinesofTBIarecontrasted accordingtoresearchmethodologiesandoutputdataformats. 1.3.1 Bioinformatics Simplydefined,bioinformaticsistheuseofcomputationaltoolstointerpretinfor- mation from genomes and their derivatives (e.g., transcriptomes, proteomes, and metabolomes). Thus, bioinformatics approaches can readily identify molecules or cellularcomponentsastargetsofclinicalinterventions,allowingforbetterknowl- edgeofthemechanismofthedisease. The bioinformatics tools have generated a variety of health data at molecular level, including gene sequences, mutations, rearrangements, and changes in the expression of RNA and proteins. The multidimensional research data have been catalogedbyanexpandingarrayofpublicdatabases.Anumberofresearchprojects such as TCGA, the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative, and the Cancer Target Discovery and Develop- ment (CTD2) Network, Tumor Microenvironment Initiative (TMEN), and the Integrative Cancer Biology Program (ICBP) have been conducted. These global data collection programs would support the genomics study and translational investigation. 1.3.2 Imaging Informatics Imaging technologies use visualization approaches to measure and monitor the pathogenesis of diseases at the tissue or organ level [19, 20]. It focuses on the interpretationoftheinformationderivedfromimagingdevices. Imaginginformaticsisexpectedtoprovidehigh-valuemedicalinformationfrom thevisualimagesforearlydiagnosisandtreatmentofdiseases.Thelargeamountof medicalimageshavealsobeenorganizedandcatalogedforpublicaccessthrough programs such as NCI’s Quantitative Imaging Network and The Cancer Imaging Archive (TCIA). In addition to data collection, these open archives also deploy a number of imaging informatics tools such as the National Biomedical Imaging Archive and RSNA Clinical Trials Processor to enable the sharing of medical imagesacrossmultipleresearchgroups.